Credit Suisse’s Syneron Medical Ltd ELOS Stock Holding History

Credit Suisse’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,176	Closed	-$94K	–	4373
2016 Q2	$94K	Buy	12,176 +1,673	+16%	+$11.9K	﹤0.01%	4072
2016 Q1	$77K	Buy	+10,503	New	+$75.2K	﹤0.01%	3860
2015 Q4	–	Sell	-10,541	Closed	-$75K	–	4470
2015 Q3	$75K	Buy	+10,541	New	+$101K	﹤0.01%	4140
2015 Q2	–	Sell	-21,854	Closed	-$271K	–	4719
2015 Q1	$271K	Buy	+21,854	New	+$242K	﹤0.01%	3914
2014 Q2	–	Sell	-11,766	Closed	-$146K	–	4909
2014 Q1	$146K	Sell	11,766 -2,577	-18%	-$30.5K	﹤0.01%	4445
2013 Q4	$176K	Buy	+14,343	New	+$149K	﹤0.01%	4367

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Credit Suisse's ELOS Position: Q3 2016 in Review

Credit Suisse sold out of Syneron Medical Ltd (ELOS) in Q3 2016, closing a stake of 12,176 shares — an estimated $94K sold.

Credit Suisse first reported a position in ELOS in Q4 2013 and held it in 6 quarters. The position peaked at $271K in Q1 2015. 65 funds tracked by Wall St. Rank hold ELOS as of Q3 2016.

Credit Suisse reported no remaining Syneron Medical Ltd position as of Q3 2016 after selling out during the quarter.
Credit Suisse sold 12,176 Syneron Medical Ltd shares in Q3 2016, an estimated $94K.
Credit Suisse first reported a position in Syneron Medical Ltd in Q4 2013 and held it in 6 quarters.
Credit Suisse's Syneron Medical Ltd position peaked at $271K in Q1 2015.
65 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.